1. HBW Insight
  2. >>Geography

Same Legislative Focus For Consumer Health As Its Hill Champions Change

 
• By Malcolm Spicer

OTC drug and dietary supplement industries still emphasize lobbying for allowing direct purchases of their [products with pre-tax health savings accounts; streamlining FDA's process for adding OTC monograph ingredients and indications; and making multivitamins eligible for purchase with food stamps. They also remain vigilant about keeping Congress' hands off DSHEA, which reaches its 25th anniversary in October.

Washington DC Capitol dome detail with waving american flag

Consumer health product industries' legislative priorities for the 116th session of Congress aren't changing from the previous session, but the same can't be said for who they look to as their Capitol Hill champions.

The OTC drug and dietary supplement industries still emphasize lobbying for allowing direct purchases of OTC drugs and dietary supplements with pre-tax health savings accounts; streamlining FDA's process for adding OTC monograph ingredients and indications; and making multivitamins eligible for

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

Some Laid Off Employees Called Back At US FDA

 
• By Sarah Karlin-Smith

Some FDA employees who were recently laid off by the Trump Administration are being called back to work, multiple sources confirmed to the Pink Sheet.

US Proposal To Remove Phenylephrine From OTC Monograph Could Stress-Test Streamlined Process

 
• By Malcolm Spicer

Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.

FDA Clears Qnovia’s NRT Inhalation IND, Commits To ‘Stimulating’ Smoking Cessation Innovation

 
• By Malcolm Spicer

Qnovia notes NRT inhalation product recently received investigational new drug clearance from FDA as agency and NIH say innovation needed smoking cessation to help improve rate of success for quitting the habit that kills around 500,000 US consumers annually.

Washington State TFCA Violators Likely To Face Conversation Before Penalties – DOE

 
• By Eileen Francis

The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”

More from North America